Biofrontera (BFRI) Return on Capital Employed (2021 - 2026)
Biofrontera (BFRI) posted quarterly Return on Capital Employed of 112.39% for Q4 2025, up 9527.0% year-over-year from 1.17% in Q4 2024, and up 66.66% quarter-over-quarter from 337.12% in Q3 2025.
Biofrontera (BFRI) Return on Capital Employed (2021 - 2026) Analysis & Trends
Biofrontera's Return on Capital Employed history runs 5 years deep, the most recent figure standing at 112.39% for Q4 2025.
- In Q4 2025, Return on Capital Employed rose 9527.0% year-over-year to 112.39%; the TTM figure through Dec 2025 stood at 112.39% (up 9527.0% YoY), while the FY2025 annual figure was 84.45%, up 4798.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 112.39%, up from 337.12% in the prior quarter.
- The five-year high for Return on Capital Employed was 1232.83% in Q2 2025, with the low at 337.12% in Q3 2025.
- The 5-year median for Return on Capital Employed is 137.78% (2024), against an average of 25.22%.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed plunged 46711 bps in 2022, then surged 137061 bps in 2025.
- Biofrontera's Return on Capital Employed stood at 409.31% in 2021, then tumbled by 114 bps to 57.8% in 2022, then plunged by 203 bps to 175.38% in 2023, then declined by 18 bps to 207.66% in 2024, then jumped by 46 bps to 112.39% in 2025.
- Business Quant data shows BFRI's Return on Capital Employed at 112.39% in Q4 2025, 337.12% in Q3 2025, and 1232.83% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.27 Bn | 43.31 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.64 Bn | 39.99 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 32.26 Bn | 30.58 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.29 Bn | 19.62 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.86 Bn | 17.98 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Biofrontera | 19.06 Mn | 14.35 Mn | 9.59 Mn | -46.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -46.42% |
| Dec 31, 2025 | -112.39% |
| Sep 30, 2025 | -337.12% |
| Jun 30, 2025 | 1,232.83% |
| Mar 31, 2025 | -194.26% |
| Dec 31, 2024 | -207.66% |
| Sep 30, 2024 | -214.83% |
| Jun 30, 2024 | -137.78% |
| Mar 31, 2024 | -185.40% |
| Dec 31, 2023 | -175.38% |
| Mar 31, 2023 | -80.56% |
| Dec 31, 2022 | -57.80% |
| Sep 30, 2022 | -39.95% |
| Jun 30, 2022 | -74.79% |
| Mar 31, 2022 | -202.54% |
| Dec 31, 2021 | 409.31% |